Acta Neurologica Scandinavica

Papers
(The median citation count of Acta Neurologica Scandinavica is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Neurological Manifestations of COVID‐19: A systematic review and current update281
Neurological side effects of SARS‐CoV‐2 vaccinations101
The potential neurological effect of the COVID‐19 vaccines: A review81
Epilepsy in time of COVID‐19: A survey‐based study70
Effect of COVID‐19 pandemic on stroke admission rates in a Norwegian population56
The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use52
Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis45
Glymphatic dysfunction in isolated REM sleep behavior disorder34
Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis34
Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials34
Parkinson’s disease and intensive exercise therapy — An updated systematic review and meta‐analysis33
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis33
Blood biomarkers for Alzheimer's disease and related disorders30
COVID‐19 presentations and outcome in patients with epilepsy30
In‐hospital acute stroke workflow in acute stroke – Systems‐based approaches30
Refractory migraine profile in CGRP‐monoclonal antibodies scenario27
Blood biomarkers in ALS : challenges, applications and novel frontiers27
Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review27
Neurophysiological impairments in multiple sclerosis—Central and peripheral motor pathways26
Air pollution, a possible risk factor for multiple sclerosis25
SARS‐CoV‐2 vaccines are not free of neurological side effects24
Persistent olfactory dysfunction after COVID‐19 is associated with reduced perfusion in the frontal lobe24
Medication adherence/persistence among patients with active multiple sclerosis in Finland24
Prevalence of non‐motor symptoms and their association with quality of life in cervical dystonia22
Systolic blood pressure variability following endovascular thrombectomy and clinical outcome in acute ischemic stroke: A meta‐analysis22
Vagus nerve stimulation in patients with Lennox‐Gastaut syndrome: A meta‐analysis21
Generalized status epilepticus as a possible manifestation of COVID‐1921
Microglia and immunotherapy in Alzheimer’s disease21
Multiple cranial nerve palsies following COVID‐19 vaccination—Case report21
Military service and related risk factors for amyotrophic lateral sclerosis20
A meta‐analysis of collateral status and outcomes of mechanical thrombectomy20
Multiple sclerosis and COVID‐19: The Swedish experience19
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials19
Guillain‐Barre syndrome following COVID‐19 vaccines: A scoping review19
Impacts of the COVID‐19 pandemic on Iranian patients with epilepsy19
Effectiveness of clinical exome sequencing in adult patients with difficult‐to‐diagnose neurological disorders18
Neurological manifestations as primary presentation of COVID‐19 in hospitalized patients18
Potassium channels and epilepsy17
Non‐motor symptoms in patients with autosomal dominant spinocerebellar ataxia17
Non‐pharmacological therapies for pain management in Parkinson's disease: A systematic review17
Leukoaraiosis severity and post‐reperfusion outcomes in acute ischaemic stroke: A meta‐analysis17
Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID‐19 pandemic17
Accuracy of NIH Stroke Scale for diagnosing aphasia16
Evidence‐based anti‐seizure monotherapy in newly diagnosed epilepsy: A new approach16
Risk factors for minor hallucinations in Parkinson's disease16
Myasthenia gravis and COVID‐19: A case series and comparison with literature16
People with epilepsy still feel stigmatized16
Blood biomarkers of peripheral neuropathy15
Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report15
A nomogram to predict mechanical ventilation in Guillain‐Barré syndrome patients15
Identifying epilepsy psychiatric comorbidities with machine learning15
Blood biomarkers in epilepsy14
Mechanical thrombectomy with or without thrombolysis: A meta‐analysis of RCTs14
Heart rate variability in frontal lobe epilepsy: Association with SUDEP risk14
Prevalence and risk of thyroid diseases in myasthenia gravis14
CTP‐guided reperfusion therapy in acute ischemic stroke: a meta‐analysis14
Supervised exercises versus telerehabilitation. Benefits for persons with multiple sclerosis14
Epilepsy and lockdown: A survey of patients normally attending a Spanish centre14
Socioeconomic consequences of multiple sclerosis—A systematic literature review14
Myositis‐specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies13
Neurological symptoms and blood neurofilament light levels13
DNA methylation of the 5′‐UTR DAT 1 gene in Parkinson's disease patients13
Machine learning analysis of heart rate variability to detect delayed cerebral ischemia in subarachnoid hemorrhage13
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis13
Clinical features and outcomes of benign recurrent vertigo: A longitudinal study13
Parkinson’s disease in Sweden—resource use and costs by severity13
Aquatic therapy in stroke rehabilitation: systematic review and meta‐analysis12
Quality of life long after temporal lobe epilepsy surgery12
Long‐term prognosis related to deep sedation in refractory status Epilepticus12
Outcomes in three cases after brivaracetam treatment during pregnancy12
Comorbidities in older patients with myasthenia gravis — Comparison between early‐ and late‐onset disease12
Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis12
Association between inflammatory response and outcome after subarachnoid haemorrhage12
Quality of life in patients with glioblastoma and their relatives12
Eslicarbazepine acetate in post‐stroke epilepsy: Clinical practice evidence from Euro‐Esli12
In‐hospital systems interventions in acute stroke reperfusion therapy: a meta‐analysis12
Efficacy of lacosamide and phenytoin in status epilepticus: A systematic review12
Myelin‐associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson's disease12
Advances in sudden unexpected death in epilepsy11
Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial11
Changes in multiple sclerosis epidemiology in Finland over five decades11
Meta‐analysis of melatonin levels in cluster headache—Review of clinical implications11
Seizure freedom as an outcome in epilepsy treatment clinical trials11
Small fiber neuropathy11
Fatigue 7 years post‐stroke: Predictors and correlated features11
Brain networks in migraine with and without aura: An exploratory arterial spin labeling MRI study11
Neuromodulation in drug‐resistant epilepsy: A review of current knowledge11
Efficacy of high‐intensity aerobic exercise on common multiple sclerosis symptoms11
Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis11
Upregulated serum miR‐128‐3p in progressive and relapse‐free multiple sclerosis patients11
Gamma knife surgery in the treatment of intracanalicular vestibular schwannomas11
Neurofunctional outcomes in patients with anti‐leucine‐rich glioma inactivated 1 encephalitis11
Therapy delay in status epilepticus extends its duration and worsens its prognosis11
Standardized mortality ratios in multiple sclerosis: Systematic review with meta‐analysis11
Early identification of epilepsy surgery candidates: A multicenter, machine learning study11
Seizure outcome trajectories in a well‐defined cohort of newly diagnosed juvenile myoclonic epilepsy patients10
Pregnancy and neurologic complications of COVID‐19: A scoping review10
Functional outcome and quality of life after meningioma surgery: a systematic review10
Progressive external ophthalmoplegia associated with novel MTTN mutations10
Ischemic stroke patients with prestroke dependency: Characteristics and long‐term prognosis10
Ketamine in adult super‐refractory status epilepticus: Efficacy analysis on a prospective registry10
Intravenous sodium valproate for acute migraine in the emergency department: A meta‐analysis10
Meta‐analysis of association between migraine and risk of dementia10
Blood based biomarkers for movement disorders10
Plasma total tau predicts executive dysfunction in Parkinson's disease10
Physical activity and cognition in young‐onset Parkinson’s disease10
Temporal lobe epilepsy with amygdala enlargement: A systematic review10
Impact of comorbidities on the disability progression in multiple sclerosis10
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke9
Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease9
Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementia9
Effects of transdermal nicotine delivery on cognitive outcomes: A meta‐analysis9
Time course of 75%–100% efficacy response of adjunctive brivaracetam9
Dynamic gray matter and intrinsic activity changes after epilepsy surgery9
Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis9
Potential role of brivaracetam in pediatric epilepsy9
Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate9
Treatment satisfaction with calcitonin gene‐related peptide monoclonal antibodies as a new patient‐reported outcome measure: A real‐life experience in migraine9
Critical illness polyneuromyopathy: Functional impact after severe acquired brain injuries9
Clinical outcomes and safety profile of Tenecteplase in wake‐up stroke9
Verbal and spatial memory spans in mild cognitive impairment9
Electrodiagnostic findings in patients with non‐COVID‐19‐ and COVID‐19‐related acute respiratory distress syndrome9
Birth characteristics and risk of febrile seizures9
Neuropsychological screening in the acute phase of cerebrovascular diseases9
Diversified social cognition in temporal lobe epilepsy9
Optical coherence tomography in patients with Wilson's disease8
Medical complications and outcome after endovascular therapy for acute ischemic stroke8
Medium‐term effects of COVID‐19 pandemic on epilepsy: A follow‐up study8
Basal IL‐6 and S100b levels are associated with infarct volume8
Prevalence and development of idiopathic normal pressure hydrocephalus: A 16‐year longitudinal study in Japan8
Association of consciousness impairment and mortality in people with COVID‐198
Bone health, intellectual disability and epilepsy: An observational community‐based study8
Is wearing a face mask safe for people with epilepsy?8
Initial cognitive impairment predicts shorter survival of patients with glioblastoma8
Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy‐related inflammation8
Swedish guidelines for device‐aided therapies in Parkinson's disease —Economic evaluation and implementation8
Brain networks in patients with isolated or recurrent transient global amnesia8
European perspective of perampanel response in people with Intellectual Disability8
Associations between seizures and MRI in patients with anti‐NMDAR encephalitis8
Incidence and mortality in adults with epilepsy in northern Spain8
Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy8
Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta‐analysis8
Severe neurological nicotine intoxication by e‐cigarette liquids: Systematic literature review8
Seizure freedom and plasma levels of newer generation antiseizure medications8
Impaired neck motor control in chronic whiplash and tension‐type headache7
Retinal thinning and brain atrophy in early MS and CIS7
Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review7
Effects of robotic rehabilitation on recovery of hand functions in acute stroke: A preliminary randomized controlled study7
Motor Band Sign in Motor Neuron Diseases Using Magnetic Resonance Imaging: A Systematic Review7
The Prehospital Stroke Score and telephone conference: A prospective validation7
Blood‐based biomarkers and traumatic brain injury—A clinical perspective7
Response to first antiseizure medication in patients diagnosed with epilepsy7
Clinical characteristics of GAD 65‐associated autoimmune encephalitis7
Sonographic pattern of median nerve enlargement in Hansen's neuropathy7
Neurological side effects of COVID‐19 vaccines are rare7
EEG patterns associated with present cortical SSEP after cardiac arrest7
Epilepsy in adult patients with tuberous sclerosis complex7
Non‐convulsive seizures and non‐convulsive status epilepticus in neuro‐intensive care unit7
Help‐seeking behaviour and subsequent patient and system delays in stroke7
Repeated infusion of autologous adipose tissue‐derived stem cells for Parkinson's disease7
Epidemiology of status epilepticus in a non‐urban area in Switzerland7
Onset of efficacy and adverse events during Cenobamate titration period7
Deep brain stimulation of the subthalamic nucleus for epilepsy7
Activities of daily living in myotonic dystrophy type 17
The impact of COVID‐19 in Dravet syndrome: A UK survey7
Non‐motor symptoms are associated with midline tremor in essential tremor7
Identification of focal epilepsy by diffusion tensor imaging using machine learning7
Definition of drug‐resistant epilepsy: A reappraisal based on epilepsy types7
Genotype‐phenotype analysis of MT‐ATP6 ‐associated Leigh syndrome7
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy7
Systemic thrombolysis in ischaemic stroke patients with COVID‐197
Epidemiology of multiple sclerosis in Santiago de Compostela (Spain)7
STN‐DBS affects language processing differentially in Parkinson's disease: Multiple‐case MEG study7
EEG spindles integrity in critical care adults. Analysis of a randomized trial7
Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta‐analysis7
Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus7
Stroke admissions and revascularization treatments in Denmark during COVID‐197
Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study7
Circulating levels of vascular endothelial growth factor and post‐stroke long‐term functional outcome7
Early post‐traumatic seizures in hospitalized patients with traumatic brain injury6
S100B and neuron‐specific enolase levels in episodic and chronic migraine6
Surgery in intractable epilepsy—physicians' recommendations and patients' decisions6
40‐Hz auditory stimulation for intracranial interictal activity: A pilot study6
Fetal posterior cerebral artery configurations in an ischemic stroke versus an unselected hospital population6
Genetic analysis reveals novel variants for vascular cognitive impairment6
Fluid biomarkers in stroke: From animal models to clinical care6
Acute stroke care during the first phase of COVID‐19 pandemic in Norway6
Topiramate, acupuncture, and BoNT‐A for chronic migraine: a network meta‐analysis6
Left ventricle end‐systolic elastance, arterial‐effective elastance, and ventricle‐arterial coupling in Epilepsy6
Switching antiepileptic drugs to once‐daily dosing regimens in epilepsy patients6
Prehospital recognition of stroke is associated with a lower risk of death6
Effect and efficacy of lifestyle interventions as secondary prevention6
Caffeinated drinks, fruit juices, and epilepsy: A systematic review6
Perceived and actual changes in gait balance after CSF shunting in idiopathic normal pressure hydrocephalus6
Narcolepsy treatment in Sweden: An observational study6
Cerebrospinal fluid CD4 + /CD8 + ratio in diagnosing neurosarcoidosis6
Sports and trauma as risk factors for Motor Neurone Disease: New Zealand case–control study6
Teleneurology in Parkinson's disease: A step‐by‐step video guide6
Plantar stimulation alters brain connectivity in idiopathic Parkinson's disease6
Cognitive change after DBS in refractory epilepsy: A randomized‐controlled trial6
Epilepsy in the time of COVID‐196
Seizure detection based on wearable devices: A review of device, mechanism, and algorithm6
Relapse factors of patients of anti‐N‐methyl‐D‐aspartate receptor encephalitis6
Multiple sclerosis among first‐ and second‐generation immigrant groups in Sweden6
End‐of‐life care in amyotrophic lateral sclerosis: A comparative registry study6
Increased level of LIGHT/TNFSF14 is associated with survival in aneurysmal subarachnoid hemorrhage6
Potential mechanism of SARS‐CoV ‐2‐associated central and peripheral nervous system impairment6
Withdrawal failure in patients with chronic migraine and medication overuse headache6
In vivo microstructural white matter changes in early spinocerebellar ataxia 26
Poststroke epilepsy incidence, risk factors and treatment: German claims analysis6
Cannabinoids in multiple sclerosis: A neurophysiological analysis6
Cannabis use in Parkinson’s disease—A nationwide online survey study5
Changing epidemiology of traumatic brain injury among the working‐aged in Finland: Admissions and neurosurgical operations5
Retinal changes associated with multivitamin deficiency before and after supplementation5
Epilepsy care and COVID‐19: A cross‐sectional online survey from Lithuania5
Levetiracetam as first‐line monotherapy for Idiopathic Generalized Epilepsy in women5
Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review5
Impact of ictal subtraction SPECT and PET in presurgical evaluation5
Subjective postural vertical in Parkinson's disease with lateral trunk flexion5
Types of occult cancer in stroke and the relation to smoking5
Greater occipital nerve block for chronic migraine patients: A meta‐analysis5
Self‐limited focal epilepsy decreased regional brain activity in sensorimotor areas5
Abnormal blood oxygen level‐dependent fluctuations and remote connectivity in sleep‐related hypermotor epilepsy5
Driving eligibility: Implications of studies on seizure recurrence risk5
Cortical remodeling before and after successful temporal lobe epilepsy surgery5
Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin5
Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes5
Oculomotor functions in focal dystonias: A systematic review5
Clinical significance of bilateral epileptiform discharges in temporal lobe epilepsy5
Minor hallucinations in isolated rapid eye movement sleep behavior disorder indicative of early phenoconversion: A preliminary study5
Theory of mind: A clue for the interpretation of functional movement disorders5
Stroke after COVID‐19 vaccination5
Effects of fast‐velocity concentric resistance training in people with multiple sclerosis: A randomized controlled trial5
Acute‐onset binocular diplopia in neurological unit: Aetiological factors and diagnostic assessment5
Diplopia in Parkinson's disease: Indication of a cortical phenotype with cognitive dysfunction?5
Quality of life and resource utilization‐Swedish data from the Care of Late‐Stage Parkinsonism (CLaSP) study5
Paediatric sudden unexpected death in epilepsy: A parental report cohort5
Treatment of occipital neuralgia using onabotulinum toxin A5
Eptinezumab for migraine prevention in patients 50 years or older5
Dopamine transporter SPECT imaging in corticobasal syndrome: A peak into the underlying pathology?4
Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy4
Direct economic burden of patients with tuberculous meningitis in western China4
Myasthenia gravis—treatment and severity in nationwide cohort4
Changes in epilepsy causes of death: A US population study4
Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy4
Long‐term effects of zonisamide in adult patients with intellectual disability4
Difficulties in the prehospital assessment of patients with TIA/stroke4
Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County4
Long‐term outcome of 200 patients referred to a first seizure clinic4
Balance and physical functioning in Spinocerebellar ataxias 3 and 104
0.038923978805542